
Five AI-enhanced clinical trial start-ups to watch in 2021
We look at some of the most exciting startups harnessing artificial intelligence to improve clinical trials.
ByWe look at some of the most exciting startups harnessing artificial intelligence to improve clinical trials.
ByEight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on the industry now the regulation…
Topias Lemetyinen, Senior Epidemiologist, GlobalData, explains why HCV continues to be an enduring issue in the US
In this Industry Viewpoint, Sarah Fal speaks to Kumar Komuravelli, Mallinckrodt Pharmaceuticals, on the arising technologies taking over the industry
CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, analyzes Moderna Therapeutics’ growing stature as the young biotech punches above its weight
CTA’s Sarah Fal interviews Terry Katz, Merck Animal Health, on the latest clinical data management trends and challenges
Audrey Hill, Senior Director, Data Management, Advaxis, Inc., explains the keys to clear communication in clinical trial processes
Thank you for subscribing to Clinical Trials Arena